Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Handman

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Experimental Parasitology|October 1, 1990
Leishmania major: expression and gene structure of the glycoprotein 63 molecule in virulent and avirulent clones and strainsP J Murray, E Handman, T A Glaser, et al.
Vaccine|May 29, 2000
Therapy of murine cutaneous leishmaniasis by DNA vaccinationE Handman, A H Noormohammadi, J M Curtis, et al.
Molecular and Biochemical Parasitology|November 1, 1995
The Leishmania promastigote surface antigen 2 complex is differentially expressed during the parasite life cycleE Handman, A H Osborn, F Symons, et al.
Biochimica Et Biophysica Acta|September 22, 2001
Molecular and immunological characterisation of the glucose regulated protein 78 of Leishmania donovani(1)A T Jensen, J Curtis, J Montgomery, et al.
Molecular and Biochemical Parasitology|August 1, 1994
Epitope mapping of monoclonal antibodies directed against lipophosphoglycan of Leishmania major promastigotesM Kelleher, J M Curtis, D L Sacks, et al.
Immunology|September 29, 2001
Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory diseaseD V Bullen, R Darwiche, D Metcalf, et al.
The Journal of Biological Chemistry|August 30, 1996
Purification and structural characterization of a filamentous, mucin-like proteophosphoglycan secreted by Leishmania parasitesT Ilg, Y D Stierhof, D Craik, et al.
Vaccine|June 28, 2001
Paradoxical effects of IL-12 in leishmaniasis in the presence and absence of vaccinating antigenA H Noormohammadi, H Hochrein, J M Curtis, et al.
Molecular and Biochemical Parasitology|April 1, 1991
An antigenically distinct lipophosphoglycan on amastigotes of Leishmania majorT A Glaser, S F Moody, E Handman, et al.
Vaccine|October 31, 1998
Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infectionA Sjölander, T M Baldwin, J M Curtis, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Experimental Parasitology|October 1, 1990
Leishmania major: expression and gene structure of the glycoprotein 63 molecule in virulent and avirulent clones and strainsP J Murray, E Handman, T A Glaser, et al.
Vaccine|May 29, 2000
Therapy of murine cutaneous leishmaniasis by DNA vaccinationE Handman, A H Noormohammadi, J M Curtis, et al.
Molecular and Biochemical Parasitology|November 1, 1995
The Leishmania promastigote surface antigen 2 complex is differentially expressed during the parasite life cycleE Handman, A H Osborn, F Symons, et al.
Biochimica Et Biophysica Acta|September 22, 2001
Molecular and immunological characterisation of the glucose regulated protein 78 of Leishmania donovani(1)A T Jensen, J Curtis, J Montgomery, et al.
Molecular and Biochemical Parasitology|August 1, 1994
Epitope mapping of monoclonal antibodies directed against lipophosphoglycan of Leishmania major promastigotesM Kelleher, J M Curtis, D L Sacks, et al.
Immunology|September 29, 2001
Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory diseaseD V Bullen, R Darwiche, D Metcalf, et al.
The Journal of Biological Chemistry|August 30, 1996
Purification and structural characterization of a filamentous, mucin-like proteophosphoglycan secreted by Leishmania parasitesT Ilg, Y D Stierhof, D Craik, et al.
Vaccine|June 28, 2001
Paradoxical effects of IL-12 in leishmaniasis in the presence and absence of vaccinating antigenA H Noormohammadi, H Hochrein, J M Curtis, et al.
Molecular and Biochemical Parasitology|April 1, 1991
An antigenically distinct lipophosphoglycan on amastigotes of Leishmania majorT A Glaser, S F Moody, E Handman, et al.
Vaccine|October 31, 1998
Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infectionA Sjölander, T M Baldwin, J M Curtis, et al.
Pageof 10